Asthma exacerbations on benralizumab are non-eosinophilic
Causes of exacerbations in patients on benralizumab for severe eosinophilic asthma are related to infection rather than eosinophilic inflammation, according to results published in The Lancet Respiratory Medicine.
“The most interesting finding was that eosinophils remained fully depleted during exacerbations in patients treated with benralizumab, not only in the blood but also within the airways,” Rekha Chaudhuri, MD, honorary professor in the school of Infection and Immunity at University of Glasgow, told Healio. “Instead, we observed evidence of airway infection, including increased